Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management (PROMOTE IBD)

NCT06424769 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT06424769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06424769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management (PROMOTE IBD)
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 24, 2024
Completion date
September 30, 2028
Enrollment
900 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, crohn disease, inflammatory bowel diseases, ulcerative colitis